Nejra Cosic-Mujkanovic

Mrs. Nejra Cosic-Mujkanovic


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 August 2023 in Antioxidants
Verified
Journal Article
Open access
PDF file
NCNejra Cosic-Mujkanovic
Nejra Cosic-Mujkanovic
PVPaulina Valadez-Cosmes
Paulina Valadez-Cosmes
KMKathrin Maitz
Kathrin Maitz
ALAnna Lueger
Anna Lueger
ZMZala Nikita Mihalic
Zala Nikita Mihalic
JKJulia Kargl
Julia Kargl
Myeloperoxidase (MPO) is a neutrophil-derived enzyme that has been recently associated with tumour development. However, the mechanisms by which this enzyme exerts its functions remain unclear. In this study, we investigated whether myeloperoxidase can alter the function of A549 human lung cancer cells. We observed that MPO promoted the proliferation of cancer cells and inhibited their apoptosis. Additionally, it increased the phosphorylation of AKT and ERK. MPO was rapidly bound to and internalized by A549 cells, retaining its enzymatic activity. Furthermore, MPO partially translocated into the nucleus and was detected in the chromatin-enriched fraction. Effects of MPO on cancer cell function could be reduced when MPO uptake was blocked with heparin or upon inhibition of the enzymatic activity with the MPO inhibitor 4-aminobenzoic acid hydrazide (4-ABAH). Lastly, we have shown that tumour-bearing mice treated with 4-ABAH had reduced tumour burden when compared to control mice. Our results highlight the role of MPO as a neutrophil-derived enzyme that can alter the function of lung cancer cells.